A guardian molecule ensures that liver cells do not lose their identity. The discovery is of great interest for cancer medicine because a change of identity of cells has come into focus as a ...

The risk of developing liver cancer is increased in people who have cirrhosis, a disease in which healthy liver tissue is ...

Innovative therapies and surgical techniques have the potential to transform liver cancer care. People with cirrhosis—a ...

Researchers describe successful tumor removal through the use of immunotherapy and targeted radiation therapy (TARE), in a patient previously considered ineligible for the procedure.

St. David’s Medical Center in Austin is the first hospital in Central Texas to offer histotripsy, a noninvasive ultrasound ...

A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the German Cancer Research Center (DKFZ), the Hector Institute für Translational ...

TheraBionic is the only FDA-approved therapy indicated in liver cancer patients that fail first-line and second-line therapy, so that's really the place it takes right now in 2025. Patients can ...

IntroductionHepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality rates. It arises from ...

You’ve got to be to check your ego at the door, man,” Randy Moss said, as he urged all to get annual check-ups and blood tests, which may catch a cancer like his before it becomes symptomatic.

Being thrown into this situation is hard because they are separate and they know that... and when they see each other it ...